GlassScriptPhysician profile
Joan Oloff
NPI 1780750711
$7,624.63
in general payments reported to CMS, 2019-2025
18 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $943 · 2021: $1,407 · 2022: $2,603 · 2023: $549 · 2024: $1,150 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894 · Travel and Lodging: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,894.19 |
| Travel and Lodging | $124.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $3,437.10 | 2020-2023 | |
| Musculoskeletal Transplant Foundation INC. | $1,451.32 | 2021-2022 | |
| Stryker Corporation | $536.96 | 2019-2025 | Actishield, Ortholoc 2 Lapifuse, Fuseforce |
| Smith+Nephew, INC. | $439.42 | 2019-2025 | Grafix, Collagenase Santyl, Stravix |
| Orthofix Medical, INC. | $360.72 | 2023-2025 | Physio-Stim |
| Organogenesis INC. | $253.87 | 2023-2024 | Puraply |
| Exactech, INC. | $212.75 | 2024 | |
| Treace Medical Concepts, INC. | $189.59 | 2024 | |
| Kerecis Limited | $173.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Zyla Life Sciences, INC. | $156.85 | 2019 | |
| Depuy Synthes Sales INC. | $115.38 | 2019 | |
| Medline Industries LP | $104.67 | 2019 | |
| Wright Medical Technology, INC. | $72.84 | 2019 | |
| Sanara Medtech INC. | $32.15 | 2023 | Celleraterx |
| Revance Therapeutics, INC. | $29.72 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $26.48 | 2019 | |
| Abbvie INC. | $19.36 | 2022 | |
| Arthrosurface Incorporated | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Oloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.